vimarsana.com

Latest Breaking News On - European medicines agency orphan designation - Page 1 : vimarsana.com

Synlogic Receives Positive Opinion on Orphan Designation from the European Medicines Agency for SYNB1934 for the Treatment of Phenylketonuria

CAMBRIDGE, Mass., March 28, 2023 Synlogic, Inc. , the leading company advancing therapeutics based on synthetic biology, today announced that the European Medicines Agency issued a. | March 28, 2023

United kingdomAoife brennanEuropean medicines agency orphan designationEuropean medicines agencyGlobenewswire incDrug administrationExchange commissionEuropean unionSynlogic incMedicines agencySynlogic presidentChief executiveRare pediatric disease designationEuropean medicines agency orphanSynthetic bioticsSynthetic biotic

Synlogic Receives Positive Opinion on Orphan Designation

CAMBRIDGE, Mass., March 28, 2023 (GLOBE NEWSWIRE) Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic.

United kingdomAoife brennanEuropean medicines agency orphan designationEuropean medicines agencyExchange commissionEuropean unionDrug administrationSynlogic incSynlogic presidentChief executiveRare pediatric disease designationEuropean medicines agency orphanSynthetic bioticsSynthetic bioticGinkgo bioworksPrivate securities litigation reform act

vimarsana © 2020. All Rights Reserved.